Braincool Investor Relations Material
Latest events
Q1 2025
2 May, 2025
Q4 2024
11 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Braincool
Access all reports
BrainCool AB is a Swedish medical device company specializing in the development, marketing, and sale of advanced medical cooling systems. The company focuses on targeted temperature management (TTM) solutions designed to protect the brain and vital organs by reducing metabolic activity and minimizing inflammation. These technologies are primarily applied in cases of cardiac arrest, stroke, and oncology-related complications such as oral mucositis caused by chemotherapy. The company is headquartered in Lund, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
BRAIN
Country
🇸🇪 Sweden